Skip to main content
. 2022 Apr 15;12:6286. doi: 10.1038/s41598-022-10139-6

Figure 6.

Figure 6

[177Lu]Lu-DOTA-NNV003 biodistribution in RAMOS xenografted mice and comparison with [89Zr]Zr-N-sucDf-NNV003. (A) Ex vivo biodistribution results of [177Lu]Lu-DOTA-NNV003 in RAMOS-tumor bearing mice at 1 h (h), 6 h, 1 day (d) and 3 days pi. Tracer uptake per organ is presented as %ID/g. Left: [177Lu]Lu-DOTA-NNV003 uptake in healthy tissues. Right: [177Lu]Lu-DOTA-NNV003 uptake in tumor. (B) [89Zr]Zr-N-sucDf-NNV003 (500 MBq/mg) and [177Lu]Lu-DOTA-NNV003 (50–90 MBq/mg) ex vivo biodistribution results at 5 days pi and 3 days pi respectively. Uptake is presented as %ID/g. Data is shown as mean ± SD. **P < 0.01, *P < 0.05, ns not significant.